Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

FDA approves Gilead’s COVID-19 treatment for young children – Outsourcing Pharma,

The injectable drug is intended for patients who are either … Patients in this pediatric Phase II/III trial received Veklury for up to 10 days., The injectable drug is intended for patients who are either … Patients in this pediatric Phase II/III trial received Veklury for up to 10 days., Read More

Scroll to Top